Clinical characteristics of potential kidney donors with asymptomatic kidney stones.

Age, kidney function, and risk factors associate differently with cortical and medullary volumes of the kidney. Kidney Int (2013) 1.77

The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int (2012) 1.68

Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events. Urology (2014) 1.48

Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol (2011) 1.34

Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol (2012) 1.15

Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens (2013) 1.11

Outcomes of living kidney donors with medullary sponge kidney. Clin Kidney J (2015) 0.98

Prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res (2012) 0.93

Do kidney stone formers have a kidney disease? Kidney Int (2015) 0.90

Ex vivo pyelotomy, nephroscopy and holmium laser lithotripsy of a staghorn stone in a donor kidney prior to renal transplant. Wideochir Inne Tech Maloinwazyjne (2015) 0.89

When (and how) to surgically treat asymptomatic renal stones. Nat Rev Urol (2012) 0.77

Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv (2012) 0.76

Kidney Function After the First Kidney Stone Event. Mayo Clin Proc (2016) 0.75

Stones: do urinary calculi increase risk of bladder pain syndrome? Nat Rev Urol (2012) 0.75

Cellular senescence in renal ageing and disease. Nat Rev Nephrol (2016) 0.75

Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers. Clin J Am Soc Nephrol (2017) 0.75

Re: Clinical characteristics of potential kidney donors with asymptomatic kidney stones. J Urol (2012) 0.75

KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 18.51

Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11

The threat to medical-records research. N Engl J Med (1997) 8.50

Obesity, weight gain, and the risk of kidney stones. JAMA (2005) 5.34

Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med (2002) 3.24

Diabetes mellitus and the risk of nephrolithiasis. Kidney Int (2005) 3.17

The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int (2004) 2.89

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int (2007) 2.69

Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22

Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol (1996) 2.17

Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol (2007) 2.02

Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int (2005) 2.00

Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis (2008) 1.91

Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91

Body size and risk of kidney stones. J Am Soc Nephrol (1998) 1.78

ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis (2004) 1.66

Nephrolithiasis and risk of hypertension. Am J Hypertens (1998) 1.56

Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1993) 1.45

Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis (1998) 1.38

History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol (2004) 1.35

Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis (2009) 1.32

Renal function in patients with nephrolithiasis. J Urol (2006) 1.27

Kidney stones and hypertension: population based study of an independent clinical association. BMJ (1990) 1.26

Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int (2008) 1.17

Diet and fluid prescription in stone disease. Kidney Int (2006) 1.12

Relationship between duration of pain and secondary signs of obstruction of the urinary tract on unenhanced helical CT. AJR Am J Roentgenol (2001) 1.01

Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med (1982) 0.99

Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol (2009) 0.97

Laboratory screening for hyperparathyroidism. Clin Chim Acta (2005) 0.88

Calciotropic hormones and nephrolithiasis. Miner Electrolyte Metab (1997) 0.88

Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones. J Clin Lab Anal (2007) 0.86

Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney. Am J Kidney Dis (2001) 0.83

Hyperparathyroidism in nephrolithiasis. Arch Intern Med (1980) 0.82

Epidemiology and outcomes of osteoporotic fractures. Lancet (2002) 13.09

A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med (2002) 8.63

Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol (2011) 8.00

DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med (2006) 7.90

Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med (2006) 7.24

Benign breast disease and the risk of breast cancer. N Engl J Med (2005) 6.84

History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc (2012) 6.54

Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46

Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev (2002) 6.38

Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21

Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med (2005) 5.94

Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet (2010) 4.75

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood (2005) 4.48

Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47

Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med (2002) 4.18

The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol (2008) 4.10

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis (2007) 3.83

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81

Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73

A reference standard for the description of osteoporosis. Bone (2007) 3.67

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol (2010) 3.47

Natural history of asymptomatic mitral valve prolapse in the community. Circulation (2002) 3.40

Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40

Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13

Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11

Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc (2002) 3.09

Obstetric complications of ureteroscopy during pregnancy. J Urol (2012) 3.00

Current issues in measurement and reporting of urinary albumin excretion. Clin Chem (2008) 2.98

Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc (2007) 2.91

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology (2003) 2.89

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood (2007) 2.87

Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87

Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA (2003) 2.81

Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol (2007) 2.80

A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg (2002) 2.68

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood (2003) 2.68

Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology (2005) 2.64

Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62

Serum aminotransferase activity and mortality risk in a United States community. Hepatology (2008) 2.61

The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol (2010) 2.60

A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol (2002) 2.60

Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol (2007) 2.58

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer. Cancer (2011) 2.58

Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc (2004) 2.55

Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int (2010) 2.51

Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol (2003) 2.47

Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol (2011) 2.47

Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc (2004) 2.43

Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res (2010) 2.40

Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol (2009) 2.37

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol (2011) 2.33

For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int (2009) 2.32

Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer (2004) 2.31

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One (2013) 2.31

Shock wave lithotripsy and diabetes mellitus: a population-based cohort study. Urology (2011) 2.26

Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.22

Long-term survival of patients with anorexia nervosa: a population-based study in Rochester, Minn. Mayo Clin Proc (2003) 2.21

Silent pain sufferers. Mayo Clin Proc (2006) 2.20

B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy. Cancer Res (2007) 2.19

Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15

Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14

Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation (2013) 2.10

A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One (2008) 2.09

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population. J Urol (2013) 2.07

Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int (2015) 2.06

Age-dependence of femoral strength in white women and men. J Bone Miner Res (2010) 2.03

Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis (2005) 2.02

PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer (2007) 2.00

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res (2011) 2.00

Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int (2009) 1.99

Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood (2006) 1.98

The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut (2006) 1.97

The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res (2011) 1.95

Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93

Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology (2009) 1.92

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause (2008) 1.92

Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol (2010) 1.91

In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res (2014) 1.90

Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89

Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol (2010) 1.89